Dose-dependent effects of IL-12 treatment to immune response induced after immunization with a recombinant respiratory syncytial virus (RSV) fusion protein fragment

By Werle B.   Fromantin C.   Alexandre A.   Kohli E.   Pothier P.  

Vaccine, Vol. 17, Iss. 23, 1999-08 ,pp. : 2983-2990

Elsevier

Access to resources Recommend Favorite

Liposome encapsulation of a soluble recombinant fragment of the respiratory syncytial virus (RSV) G protein enhances immune protection and reduces lung eosinophilia associated with virus challenge

By Mader D.   Huang Y.   Wang C.   Fraser R.   Issekutz A.C.   Stadnyk A.W.   Anderson R.  

Vaccine, Vol. 18, Iss. 11, 2000-01 ,pp. : 1110-1117

Elsevier

Access to resources Recommend Favorite

Immune responses of lambs to the fusion (F) glycoprotein of bovine respiratory syncytial virus expressed on insect cells infected with a recombinant baculovirus

By Sharma A.K.   Woldehiwet Z.   Walrevens K.   Letteson J.  

Vaccine, Vol. 14, Iss. 8, 1996-06 ,pp. : 773-779

Elsevier

Access to resources Recommend Favorite

CpG containing oligodeoxynucleotides are potent adjuvants for parenteral vaccination with the fusion (F) protein of respiratory syncytial virus (RSV)

By Hancock G.E.   Heers K.M.   Smith J.D.   Scheuer C.A.   Ibraghimov A.R.   Pryharski K.S.  

Vaccine, Vol. 19, Iss. 32, 2001-09 ,pp. : 4874-4882

Elsevier

Access to resources Recommend Favorite

Comparison of the T helper cell response induced by respiratory syncytial virus and its fusion protein in BALB/c mice

By Turnbull T.   Toms G.L.   Scott R.   Bright H.  

Vaccine, Vol. 13, Iss. 10, 1995-07 ,pp. : 915-922

Elsevier

Access to resources Recommend Favorite